Skip to main content
. Author manuscript; available in PMC: 2015 Mar 10.
Published in final edited form as: Addict Biol. 2012 Jan 19;18(2):332–343. doi: 10.1111/j.1369-1600.2011.00419.x

Figure 1.

Figure 1

Mean values (n=8) for the visual analog scale “How much do you LIKE the drug?” as rated by the participants are shown for oral (top row) and intranasal (bottom row) oxycodone as a function of 2-hr pretreatment dose of aprepitant at 0 mg (left column), 40 mg (middle column) and 200 mg (bottom column). Statistical analyses revealed significant main effects of oral (F[2,14]=31.8; p<.001) and intranasal oxycodone (F[2, 14]= 36.9; p<.001) as well as significant time dependent effects (df 16,112; p<.001) for both routes (F=16.6 p.o., & F= 21.5 i.n.).